Biorepository for Necrotizing Enterocolitis
T
Troy Markel, MD
Primary Investigator
Enrolling By Invitation
100 years and younger
All
Phase
N/A
35 participants needed
1 Location
Overview
We aim to provide a Necrotizing Enterocolitis (NEC) specimen biorepository to promote, facilitate and accelerate basic and clinical/translational studies of NEC in human infants.
Description
The purpose of this repository is to develop a national biorepository for infants diagnosed with Necrotizing Enterocolitis (NEC) and control premature infants for the identification of biomarkers that can predict the development of NEC.
The birth mother and baby's involvement in the study will last as long as the baby is in the NICU. During the study, blood, stool, urine, saliva and stomach fluid samples are collected from the baby and breast milk samples are collected from the birthing mother. Information from the medical records of both baby and birthing mother is also collected.
This study is being conducted at Indiana University by Dr. Troy Markel. It is being managed by the University of North Carolina. It is funded by the National Institute of Health.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Necrotizing enterocolitis, NEC
-
Age: - 100 Years
-
Gender: All
Inclusion Criteria:
- IAll infants born between 22 to 42 weeks gestation admitted to the NICU who develop NEC. There will also be aged matched controls which will include infants of a matched gestational and postmaturational age who have not developed NEC.
- Mothers of infants with gestational age of 22 to 42 weeks admitted to the Neonatal Intensive Care Unit (NICU).
Exclusion Criteria:
- Infants with any major congenital anomalies.
Updated on
01 Aug 2024.
Study ID: 14403, SURG-UNC-NEC-BIOREPOSITORY
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
